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Introduction
To date, immune-modulatory treatments in sepsis have
proved unsuccessful. Better understanding of inflamma-
tory processes might help tailor such therapies more effec-
tively and improve their efficacy. It is now recognised that
some patients may require immune stimulating therapies.
Monocytes display altered behaviour in response to
systemic inflammation; this has been called “deactiva-
tion” and is characterised by reduced HLA-DR expres-
sion and attenuated tumour necrosis factor-a (TNF)
release in response to lipopolysaccharide (LPS)
stimulus1. TNF converting enzyme (TACE), activated
via p38-mitogen activated protein kinase (MAPK)
mediated pathway2, is essential for the shedding of TNF
and TNF receptors (TNFRs)-1&2. Altered TACE beha-
viour may be mechanistically important in deactivation.
Objectives
To determine whether monocyte TACE activity is
affected by sepsis and is reflective of illness severity.
Methods
Sixteen patients with sepsis, 15 healthy volunteers and 8
patients with non-infectious systemic inflammatory
response syndrome (NI-SIRS) were recruited and data
collected at baseline (D0), day 2 (D2) and day 4 (D4).
Peripheral blood mononuclear cells were separated by
density gradient centrifugation with HLA-DR, TACE
and TNFR expression (basal and LPS-induced) deter-
mined by flow cytometry. LPS-induced TNF release was
measured using ELISA. Monocytes were isolated using
magnetic bead selection and TACE catalytic activity
(basal and LPS-induced) was measured using fluores-
cence resonance energy transfer assay3.
Results
HLA-DR expression and LPS-induced monocyte TNF
release were attenuated in sepsis and NI-SIRS (p < 0.01),
consistent with deactivation. Sepsis, but not NI-SIRS,
produced elevated basal monocyte TACE activity (p <
0.01) while LPS-induced increases in TACE activity were
attenuated. Elevated D0 basal TACE activity positively
correlated with APACHE II score in sepsis (p < 0.01), but
not NI-SIRS.
TACE expression was unaltered across all groups, but
LPS-induced TNFR shedding appeared reduced by sep-
sis. Sepsis patients displayed an attenuated p38-MAPK
response to LPS.
Conclusions
Our data indicate that sepsis induces specific changes in
monocyte TACE catalytic activity profiles that may
reflect illness severity, whilst such changes were not seen
in NI-SIRS. These changes in TACE activity attenuated
LPS-induced release of TNFR and TNF from monocytes,
and appear to be mediated through altered upstream
p38-MAPK signalling.
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